Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: June 21, 2021

Investigation Starts in 5 States After Imported of Dog Develops Rabies A public health investigation is underway in Pennsylvania, Illinois, Indiana, New Jersey...

AHA News: Should Rare Cases of Heart Inflammation Put Your COVID-19 Vaccine Plans on Hold?

MONDAY, June 21, 2021 (American Heart Association News) -- A possible link between some COVID-19 vaccines and heart inflammation bears close monitoring, but...

Sharing Bed With Baby: Dangerous, and It Won't Boost 'Attachment,' Study Shows

MONDAY, June 21, 2021 -- Whether to share your bed with your infant at night has been the subject of heated debate: The American Academy of Pediatrics (AAP)...

Can Your Blood Pressure Medicine Protect Your Memory?

MONDAY, June 21, 2021 -- Older adults who use certain blood pressure drugs may retain more of their memory skills as they age, a new study...

'Blame Pandemic' Best Way to Save Relationships During Lockdown

MONDAY, June 21, 2021 -- Job stress, money problems and other everyday frustrations can undermine relationships, but big challenges like the coronavirus...

AHA Advises OSA Screening for Those With CV Risk, Conditions

MONDAY, June 21, 2021 -- People with cardiovascular risk factors or conditions should be screened for obstructive sleep apnea (OSA), according to a scientific...

Myocarditis-Like Illness Reported After COVID-19 Vaccination

MONDAY, June 21, 2021 -- In a research letter published online June 16 in Circulation, seven cases are presented of patients hospitalized for acute...

Outcomes Examined for Primary Nephrotic Syndrome in Adults

MONDAY, June 21, 2021 -- Adults with primary nephrotic syndrome (NS) experience higher adjusted rates of end-stage kidney disease (ESKD), cardiovascular...

Stereotactic Body Radiotherapy Aids Spinal Metastasis Pain

MONDAY, June 21, 2021 -- Stereotactic body radiotherapy is superior to conventional external beam radiotherapy for improving the complete response rate for...

Certain Antihypertensive Agents May Aid Cognition in Elderly

MONDAY, June 21, 2021 -- Blood-brain barrier-crossing renin-angiotensin drugs seem to be associated with better memory recall in seniors, according to a study...

FDA Approves Astepro Allergy (azelastine) Nasal Spray for Over-the-Counter Use

WHIPPANY, N.J.--(BUSINESS WIRE) June 17, 2021-- Bayer announced today that the U.S. Food and Drug Administration (FDA) has approved Astepro Allergy (Azelastine...

FDA Approves Blueprint Medicines' Ayvakit (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis

First precision therapy that specifically targets the primary driver of the disease Durable clinical responses, including complete remissions, shown in...

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia

DEER PARK, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that the U.S. Food and Drug Administration (FDA)...

Incyte Announces U.S. FDA Has Extended the New Drug Application Review Period for Ruxolitinib Cream for the Treatment of Atopic Dermatitis

WILMINGTON, Del.--(BUSINESS WIRE) June 11, 2021 -- Incyte Corporation (Nasdaq:INCY) announced today that the U.S. Food and Drug Administration (FDA) has...

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has...

Adamis Provides Update on Zimhi

SAN DIEGO, June 09, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that the U.S. Food and Drug Administration (FDA)...

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

BOSTON--(BUSINESS WIRE)--Jun. 9, 2021-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved...

BeyondSpring Announces U.S. FDA Acceptance And Priority Review Of New Drug Application For Plinabulin And G-CSF Combination For The Prevention Of Chemotherapy-Induced Neutropenia (CIN)

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) — BeyondSpring Inc. (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global...

CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis

SEATTLE, June 1, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New...

Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis

CAMBRIDGE, Mass. and TOKYO, June 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering...

Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously

COVID-19 vaccine candidate efficacy in those 18 to <65 years old was preserved in influenza vaccine recipients Influenza vaccine immunogenicity...

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

93% efficacy against predominantly circulating Variants of Concern and Variants of Interest 91% efficacy in high-risk populations 100% efficacy against...

Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine

New vaccine based on the recombinant spike protein antigen (rS-B.1.351) from Beta (B.1.351) virus lineage highly immunogenic in mice and produced...

New Pivotal Data at EHA 2021 Reinforces Sutimlimab as a First-in-Class Investigational C1s Inhibitor with the Potential to be the First Approved Treatment for Hemolysis in People with Cold Agglutinin Disease

PARIS – June 11, 2021 – Results from Part A of CADENZA, a pivotal Phase 3 double-blind, placebo-controlled study evaluating the safety and efficacy...

Acer Therapeutics Plans Clinical Trial for Edsivo (celiprolol) Following Type B FDA Meeting

NEWTON, MA –June 10, 2021 – Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and...

Browse by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.